Background: Seizures, traumatic brain injury (TBI), and dementia increase in prevalence with age. However, the role of seizure and TBI on cognitive impairment risk (CI) is unclear. This study investigated how a diagnosis of seizures and TBI was associated with the progression to CI and assessed the role of medications.
Method: We analyzed data from the National Alzheimer's Coordinating Center (NACC) (June 2020 data-freeze). Inclusion criteria required participants 1) aged 65 years or older at their first visit, 2) cognitively normal at baseline (Clinical Dementia Rating [CDR] score of 0), and 3) complete information on race, age, gender, and education. 8,139 participants were included and followed until dropout or the first instance of CI progressing CDR 0 to 0.5. Seizure and TBI were determined by the clinician's judgment based on medical history and the participant's annual visits. Medication categories were derived by NACC using Ultum/Lexi-Comp© therapeutic drug categories. Age, sex, race/ethnicity, and education were included as control variables. Cox proportional hazards model examined the associations between the diagnosis of seizure, TBI, or both and the progression of cognitive impairment measured by CDR. To account for selection bias, we applied propensity score weighting (PSW) with the inverse probability treatment weighting (IPSW) technique.
Result: Unadjusted survival models found a diagnosis of seizures significantly increased the hazard ratio (HR) of CI progression by 58% (p < 0.05), while the diagnosis of TBI increased the HR by 28% (p < 0.05). After applying IPSW to reduce the selection biases, the diagnosis of seizures increased the HR for CI by 39% (p < 0.05), TBI increased it by 25% (p < 0.001), and having both seizure and TBI diagnoses increased the risk of CI by 56% (p < 0.05). The use of antipsychotic, anxiolytic, sedative, or hypnotic agents and angiotensin-converting enzyme (ACE) inhibitors was found to reduce the risk of CI significantly.
Conclusion: The presence of seizure or TBI was significantly associated with the increased risks of CI. Antipsychotic, anxiolytic, sedative, or hypnotic agents and angiotensin-converting enzyme (ACE) inhibitors were associated with a reduced risk, emphasizing the importance of early treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.092832 | DOI Listing |
Background: Seizures, traumatic brain injury (TBI), and dementia increase in prevalence with age. However, the role of seizure and TBI on cognitive impairment risk (CI) is unclear. This study investigated how a diagnosis of seizures and TBI was associated with the progression to CI and assessed the role of medications.
View Article and Find Full Text PDFFront Neurol
December 2024
Department of Human Repair, Neurosurgery, Ghent University, Ghent, Belgium.
Am J Emerg Med
December 2024
University of Kentucky HealthCare, 800 Rose Street, Lexington, KY, 40536, USA.
Traumatic Brain Injury (TBI) remains a significant global health concern with significant impact on morbidity and mortality. This narrative review explores adjunctive pharmacologic agents to be employed by emergency medicine clinicians during Advanced Trauma Life Support (ATLS) in patients presenting with a TBI. Pharmacologic agents are commonly employed for the management of rapid sequence intubation and post-intubation analgosedation, hemodynamics, intracranial pressure, coagulopathy, seizure prophylaxis, and infection.
View Article and Find Full Text PDFEpilepsy Behav
December 2024
Translational Neuropharmacology Lab, NIFE, Department of Experimental Otology of the ENT Clinics, Hannover Medical School, Hannover, Germany. Electronic address:
The ethical use of laboratory animals requires that the benefits of an experimental study are carefully weighed against potential harm to the animals. In traumatic brain injury (TBI) research, ethical concerns are especially relevant to severe TBI, after which animals may experience suffering, depending on the implementation of refinement measures such as (1) postsurgical analgesia during the initial period following TBI and (2) humane endpoints. However, despite the frequent use of rodent models such as fluid percussion injury (FPI) and controlled cortical impact (CCI) in rats or mice, there is only one recent study that applied assessment of welfare to a severe TBI model, the FPI model in rats.
View Article and Find Full Text PDFJAMA Netw Open
December 2024
Weill Institute for Neurosciences, University of California, San Francisco.
Importance: Traumatic brain injury (TBI) is associated with chronic medical conditions. Evidence from diverse clinical administrative datasets may improve care delivery.
Objective: To characterize post-TBI risk of incident neuropsychiatric and medical conditions in a California health care system administrative database and validate findings from a Massachusetts dataset.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!